Dyne Therapeutics, Inc. Insider Transactions
Dyne Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
McNeill Jonathan
CBO |
Sell | 34,663 @ $25.46 | $882,520 | 196,521 | 03/08/2024 | 03/13/2024 | |
|
McNeill Jonathan
CBO |
Sell | 54,648 @ $26.72 | $1.46 M | 141,873 | 03/08/2024 | 03/13/2024 | |
|
McNeill Jonathan
CBO |
Sell | 689 @ $27.31 | $18,817 | 141,184 | 03/08/2024 | 03/13/2024 | |
|
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 30,755 @ $25.31 | $778,409 | 177,452 | 03/08/2024 | 03/12/2024 | |
|
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 55,208 @ $26.72 | $1.48 M | 122,244 | 03/08/2024 | 03/12/2024 | |
|
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 289 @ $27.33 | $7,898 | 121,955 | 03/08/2024 | 03/12/2024 | |
|
Brumm Joshua T
CEO |
Sell | 202,238 @ $25.30 | $5.12 M | 715,490 | 03/08/2024 | 03/12/2024 | |
|
Brumm Joshua T
CEO |
Sell | 160,670 @ $26.72 | $4.29 M | 554,820 | 03/08/2024 | 03/12/2024 | |
|
Brumm Joshua T
CEO |
Sell | 435 @ $27.38 | $11,910 | 554,385 | 03/08/2024 | 03/12/2024 | |
|
Brumm Joshua T
CEO |
Sell | 9,086 @ $25.85 | $234,873 | 554,385 | 03/07/2024 | 03/11/2024 | |
|
Beskrovnaya Oxana
Chief Scientific Officer |
Sell | 2,373 @ $25.85 | $61,342 | 154,433 | 03/07/2024 | 03/11/2024 | |
| Sell | 1,591 @ $25.85 | $41,127 | 186,291 | 03/07/2024 | 03/11/2024 | ||
|
Farwell Wildon
Chief Medical Officer |
Sell | 8,364 @ $25.80 | $215,791 | 154,732 | 03/07/2024 | 03/11/2024 | |
|
Farwell Wildon
Chief Medical Officer |
Sell | 1,557 @ $26.20 | $40,793 | 153,175 | 03/07/2024 | 03/11/2024 | |
|
McNeill Jonathan
CBO |
Sell | 2,434 @ $25.85 | $62,919 | 141,184 | 03/07/2024 | 03/11/2024 | |
|
Scalzo Richard William
SVP, Head of Finance & Admin. |
Sell | 2,273 @ $25.85 | $58,757 | 121,955 | 03/07/2024 | 03/11/2024 | |
|
Rhodes Jason P
Director |
Sell | 29,435 @ $30.05 | $884,522 | 1,458,691 | 03/01/2024 | 03/05/2024 | |
|
Rhodes Jason P
Director |
Sell | 17,099 @ $30.05 | $513,825 | 847,388 | 03/01/2024 | 03/05/2024 | |
|
Atlas Venture Opportunity Fund I, L.P.
10 percent owner |
Sell | 29,435 @ $30.05 | $884,522 | 1,458,691 | 03/01/2024 | 03/05/2024 | |
|
Atlas Venture Opportunity Fund I, L.P.
10 percent owner |
Sell | 17,099 @ $30.05 | $513,825 | 847,388 | 03/01/2024 | 03/05/2024 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Dyne Therapeutics, Inc. FAQ's
The list of insiders at Dyne Therapeutics, Inc. includes McNeill Jonathan, Scalzo Richard William, Beskrovnaya Oxana, Farwell Wildon, HIGH SUSANNA GATTI.
Insiders have sold a total of 218,348 Dyne Therapeutics, Inc. shares in the last 12 months for a total of 6.99 M sold.
The following insiders have sold Dyne Therapeutics, Inc. shares in the last 12 months: McNeill Jonathan ($135,553), Scalzo Richard William ($162,941), Beskrovnaya Oxana ($1.15 M), Farwell Wildon ($149,738), HIGH SUSANNA GATTI ($5.40 M),